Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.47 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.47 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.47 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.47 |
| ▸ | CYP2F1 | P24903 | 1/20 | 0.47 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13658604 | 0.97 | ALDH1A1 (0.51) | ALDH1A1LMNAADORA3CYP1A1CYP1B1 | |
| SCHEMBL6678654 | 0.84 | CYP1A1 (0.58) | ALDH1A1LMNAADORA3CYP1A1CYP1B1 | |
| SCHEMBL12810983 | 0.84 | NPC1 (0.62) | ALDH1A1CYP3A4CRHR1NPC1RAB9A | |
| SCHEMBL8767871 | 0.81 | NPC1 (0.62) | ALDH1A1CYP3A4CRHR1NPC1RAB9A | |
| SCHEMBL30174369 | 0.81 | NPC1 (0.62) | ALDH1A1CYP3A4CRHR1NPC1RAB9A | |
| SCHEMBL10486300 | 0.77 | NPC1 (0.71) | ALDH1A1ADORA3CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL6681453 | 0.77 | NPC1 (0.66) | ALDH1A1ADORA3CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL8378539 | 0.77 | NPC1 (0.66) | ALDH1A1ADORA3CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL18900675 | 0.74 | KDM4E (0.68) | ALDH1A1LMNAADORA3CYP1A1CYP1B1 | |
| SCHEMBL196689 | 0.74 | CYP1A1 (0.69) | ALDH1A1LMNACYP1A1CYP1B1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090263655-A1 | DYE MIXTURES | HUNTSMAN INTERNATIONAL LLC (US) | 2009-10-22 | — | — | US | disclosed |
| US-7527656-B2 | Process for the thermal and photochemical stabilization of dyed polyamide fiber material | HUNTSMAN INTERNATIONAL LLC (US) | 2009-05-05 | — | — | US | disclosed |
| US-20070011822-A1 | treating polyhexamethylene adipamide fiber material (carpets), before, during or after a dyeing or printing in an aqueous medium, with a stabilizer mixture containing a triazine compound such as dithio-1,3,5-triazines or thio-1,3,5-triazine compounds; colorfastness, phostability, oxidation resistance | HUNTSMAN INTERNATIONAL LLC | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070011822-A1 | treating polyhexamethylene adipamide fiber material (carpets), before, during or after a dyeing or printing in an aqueous medium, with a stabilizer mixture containing a triazine compound such as dithio-1,3,5-triazines or thio-1,3,5-triazine compounds; colorfastness, phostability, oxidation resistance | TAAR5, TMT1A, TAAR1 | ALDH1A1 496/4885LMNA 3041/4885ADORA3 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.